Miles White

Type: Person
Name: Miles White (Miles D. White)
Title: Chairman and chief executive officer
Organization: Abbott Laboratories
Date of Birth: 1955
Place of Birth: Minneapolis, Minnesota
Nationality: United States
Fact Sheet: Biography for Miles White
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Abbott CEO chides critics of corporate inversions | Medtech Wall Street news for the week of July 21, 2014

by Here's a look at some of the top Wall Street stories for medical device companies this week: Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Allergan cuts 1,500 jobs, faces SEC complaint; ... [Published MassDevice - Jul 24 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Abbott would gain big time if it made like AbbVie

Never shy, Abbott Laboratories CEO Miles White has waded right into the growing controversy over U.S. companies claiming foreign residence for tax purposes.“The raging debate about these decisions has been absurd,” Mr. White wrote in a Wall Street Journal ... [Published Crains ChicagoBusiness - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

JEFF JACOBY Inverters aren’t deserters

THE CORPORATE inversions just keep on coming, and the White House and its allies are calling them unpatriotic. But it’s a funny sort of “patriotism” that insists American businesses put the Treasury’s insatiable appetite for revenue ahead of the best ... [Published Boston Globe - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Morning 10: CPS budget 'gimmick' | Illinois venture funding | McDonald's vs. Kellogg's

1. Watchdog group shreds CPS 'gimmick-based' budgetThe Civic Federation's review of Chicago Public Schools' proposed 2015 budget depicts a system that seemingly has lost the will to do anything but spend increasing amounts of money it doesn't have, writes ... [Published Crains ChicagoBusiness - Jul 23 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Tax inversion not cheating or unpatriotic: Abbott CEO

The chief executive of Abbott Laboratories has leapt to the defence of US companies moving their tax domicile abroad, as AbbVie and Mylan start looking to complete acquisitions allowing them to do just that.Industry veteran Miles White has written an ... [Published Pharma Times - Jul 21 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Abbott CEO defends inversions amid corporate exodus furor

by Abbott chairman & CEO Miles White chides critics of corporate inversions as Capitol Hill mulls legislation to strip tax benefits for companies that shift their headquarters overseas.Abbott  (NYSE: ABT ) chairman & CEO Miles White took to the media ... [Published MassDevice - Jul 18 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 2 reports

Abbott sells developed market generics business to Mylan

:36 in Medical Company Restructures Abbott has announced the sale of its developed markets branded generics pharmaceuticals business to Mylan as part of a wider strategic refocusing. The company has exchanged the business unit for equity ownership of ... [Published Zenopa - Jul 17 2014]
First reported Jul 14 2014 - Updated Jul 15 2014 - 3 reports

Mylan buys Abbott’s non-US generics in $5.3bn

Mylan yesterday agreed to buy Abbott's specialty and branded generics business in developed markets outside the US.In return Abbott will gain part ownership in a newly formed business that will combine Mylan's existing business and Abbott's pharmaceutical ... [Published PMLive - Jul 15 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

Tax M&A: Mylan Goes Dutch With Abbott Unit

The push for U.S. companies to move overseas kept investors busy Monday as Mylan agreed to buy part of Abbott Laboratories' generic-drug business and relocate to the Netherlands. Mean while, Abbott's former proprietary-drug unit AbbVie closed in on a ... [Published Yahoo! Finance - Jul 15 2014]
First reported Jul 14 2014 - Updated Jul 15 2014 - 4 reports

Abbott Labs Sharpens Device Focus with $5 Billion Sale

Maybe they should change their name to Abbott Engineering.Abbott Park, IL–based Abbott Laboratories continues to divest itself of pharmaceutical holdings as it focuses more attention on medical devices and diagnostics, with the latest deal involving the ... [Published QMED - Jul 15 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 3 reports

Abbott CEO aims to boost medical device line, Reuters says

Abbott Laboratories CEO Miles White said the company is interested in boosting its medical device line, but it is becoming increasingly challenging to find suitable and affordable products, according to Reuters, citing comments from White.Health Care ... [Published Yahoo! Finance - Jul 14 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 3 reports

Fonterra and Abbott seal JV for farm hub

NEW Zealand’s Fonterra Co-operative Group and US healthcare and pharmaceutical giant Abbott said they will invest US$300 million in a joint venture to set up a dairy farm hub in China to tap the growing demand for high quality raw milk source.The joint ... [Published Shanghai Daily - Jul 11 2014]

Quotes

"that wasn't something anybody anticipated, it wasn't something anybody wanted to happen, including fonterra. but when it happens, it does set you back a bit" White told analysts
"we're ahead of our expectations through the first half of the year and are raising our eps guidance range as we continue to shape the company for long-term growth" said Miles White, chairman and chief executive of Abbott
...with Fonterra, a global leader in dairy science, on this alliance to build dairy capacity in China," said Abbott CEO and Chairman Miles White. "this is a very important step in our growing commitment to chinese consumers."

More Content

All (60) | News (58) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Abbott CEO chides critics of corporate inversio... [Published MassDevice - Jul 24 2014]
Abbott would gain big time if it made like AbbVie [Published Crains ChicagoBusiness - Jul 23 2014]
Morning 10: CPS budget 'gimmick' | Illinois ven... [Published Crains ChicagoBusiness - Jul 23 2014]
JEFF JACOBY Inverters aren’t deserters [Published Boston Globe - Jul 23 2014]
Transcript: Friday, July 18, 2014 [Published NBR.com - Jul 21 2014]
Tax inversion not cheating or unpatriotic: Abbo... [Published Pharma Times - Jul 21 2014]
Abbott, Fonterra Team To Build Milk Farm In China [Published China Retail News - Jul 20 2014]
AbbVie successfully plays the tax game [Published Crains ChicagoBusiness - Jul 18 2014]
Abbott CEO defends inversions amid corporate ex... [Published MassDevice - Jul 18 2014]
Look for alternatives to rein in inversions — C... [Published Politico - Jul 18 2014]
Abbott sells developed market generics business... [Published Zenopa - Jul 17 2014]
Abbott making 'progress' repairing Fonterra bot... [Published Nutra Ingredients USA - Jul 17 2014]
Abbott Labs 2nd-quarter revenues rise 1.9% [Published Pharma Letter - Jul 17 2014]
Medtronic could face legislative pushback in ta... [Published FierceMedicalDevices - Jul 16 2014]
Will Abbott Rule the Diagnostics Market by 2019? [Published Medical Device & Diagnostic Industry - Jul 16 2014]
Abbott Labs Gets No Respect Despite a Healthy S... [Published TheStreet.com - Jul 16 2014]
Abbott Labs Gets No Respect Despite a Healthy S... [Published The Street Latest - Jul 16 2014]
China to get new dairy hub [Published CHINAdaily - Jul 16 2014]
Abbott Laboratories' (ABT) CEO, Miles White on ... [Published Seeking Alpha - Jul 16 2014]
Abbott med tech revenues up slightly as company... [Published FierceMedicalDevices - Jul 16 2014]
Sanofi Talked With Abbott, Mylan, Funds on Matu... [Published Washington Post - Jul 16 2014]
Abbott Asset Sale Gives Ammunition for Perrigo [Published Bloomberg - Jul 16 2014]
Abbott beats profit estimate, infant formulas r... [Published Sharenet - Jul 16 2014]
Abbott reports meager medical device sales grow... [Published MassDevice - Jul 16 2014]
Abbott Shares Rise On Bottom-Line Beat And Lift... [Published Forbes.com - Jul 16 2014]
Abbott Raises Forecast After Sales Grow Across ... [Published Bloomberg - Jul 16 2014]
Abbott Q2 Profit Declines, But Results Beat Vie... [Published RTTNews.com - Jul 16 2014]
Mylan buys Abbott’s generics business for $5.3bn [Published In-Pharmatechnologist - Jul 16 2014]
Consolidation is reshaping pharmaceutical industry [Published San Francisco Chronicle - Jul 16 2014]
Big deals further pharmaceutical consolidation [Published Macon Telegraph - Jul 15 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.